Latest on Ratan Tata’s investment platter is a cancer therapeutic startup!
Advertisement
Advertisement
Tata has pumped money in
It has been validated in multiple cancer models.
"I have admired Ratan Tata's insights and astute assessment of technology for decades now, So I am thrilled he has invested in Invictus, which is not just developing ground-breaking innovations for cancer treatment, but is also among the very first startups based out of India to tread the path of novel discovery and biotech innovation," said Raghunath A. Mashelkar, co-founder of Invictus Oncology.
Year 2016 is going great for Tata as this was his fifth investment of this year.
Advertisement
This Delhi-based also claims it has already developed a "deep pipeline of molecules," which address a $20 billion market opportunity in the oncology space.
The investment in Invictus Oncology will add to Tata’s rapidly expanding portfolio of almost 30 investments made over the last 12-18 months.
Advertisement
- I spent $2,000 for 7 nights in a 179-square-foot room on one of the world's largest cruise ships. Take a look inside my cabin.
- Saudi Arabia wants China to help fund its struggling $500 billion Neom megaproject. Investors may not be too excited.
- Colon cancer rates are rising in young people. If you have two symptoms you should get a colonoscopy, a GI oncologist says.
- Groww receives SEBI approval to launch Nifty non-cyclical consumer index fund
- Retired director of MNC loses ₹25 crore to cyber fraudsters who posed as cops, CBI officers
- Hyundai plans to scale up production capacity, introduce more EVs in India
- FSSAI in process of collecting pan-India samples of Nestle's Cerelac baby cereals: CEO
- Narcissistic top management leads to poor employee retention, shows research